WhiteLab Genomics

Unleashing the potential of DNA and RNA based therapies using AI

Y CombinatorWinter 2022ActiveHealthcareDrug Discovery and DeliveryArtificial IntelligenceGene TherapyCell TherapyGenomics

What they do

Problem

Developing and optimizing DNA- and RNA-based genomic therapies is slow, complex, and resource-intensive.

Solution

An AI-driven platform that accelerates discovery and design of genomic therapies including cell, RNA, and DNA therapies.

Who it's for

Biopharma companies and research teams developing genomic therapies.

Founders

David Delbourgo

Founder

23 y of experience in healthcare innovation with multiple executive roles in Business Development, Marketing and Commercial Operations. Former GE Healthcare. MBA Chicago Booth, Biomedical Engineer MS University of Compiègne, France.

LinkedIn · X

Julien Cottineau

Founder

Senior application scientist at Genomic Vision, leading provider of genetic devices and platform Research fellow at Rockefeller Univ & Necker Hospital on human complex immune deficiencies in J-L Casanova’s lab PhD in genetics, molecular biology & immunology at Université Pierre & Marie CurieWith Honors